Carpe Antiperspirant For Feet
FDA Label NDC 52261-4700

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cosco International, Inc. for the product Carpe Antiperspirant For Feet (NDC 52261-4700). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, use, warnings, do not use, stop use and ask a doctor if, ask doctor before use if, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active Ingredient                                                     Purpose
Aluminum Sesquicholorhydrate 15% .......................Antiperspirant

Otc - Purpose

Anti-perspirant

Use

  • Reduces feet perspiration

Warnings

For external use only

Do Not Use

  • on broken or irritated skin

Stop Use And Ask A Doctor If

  • rash or irritation occurs

Ask Doctor Before Use If

  • you have kidney disease

Keep Out Of Reach Of Children

  • If swallowed, get medical help or contact a Poison Control Center right away

Directions

  • Wash and dry soles throughly before application
  • Apply a small, dime-sized amount of Carpe to soles
  • Rub Carpe into soles vigorously for 15 seconds
  • For best results, apply every night before bed and an additional two times per day for at least four weeks

Inactive Ingredients

Aqua (Water), C12-15 Alkyl Benzoate, Citric Acid, Dimethicone, Ethylhexylglycerin, Eucalyptus Globulus Leaf Oil, Glycerin, Hydroxypropyl Methylcellulose, Isopropyl Alcohol, Isopropyl Myristate, Phenoxyethanol, Polysorbate-20, Silica, Silica Silylate, Sodium Hydroxide, Talc

Questions?

Call 888-621-0135

Package Label.Principal Display Panel

* Please review the disclaimer below.